Need help?

Newly Established Alternative Medicine Company Investment Opportunity in Milan, Italy

Invest in a non-operational Italian GMP EU facility planning THC, CBD-API production for pharmacies.
This Business is on a Premium Plan
Established 0-1 year(s)
Employees 2 - 5
Legal Entity Private Limited Company
Reported Sales Nil
Run Rate Sales Nil
EBITDA Margin Nil
Industries Alternative Medicine
Locations  Milan
Local Time 3:25 AM Europe / Rome
Listed By Advisor / Business Broker
Status Active
Overall Rating
Partial Stake Sale
USD 3.15 million for 49.0% stake (Native Currency: EUR 3,000,000)
Reason: The funding will be utilised for: - Bioequivalence tests and the availability of the substitute dru... View More
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Business Overview
- Located in Milan, the business will operate a GMP EU-certified facility specializing in therapeutic cannabis production.
- The company will supply Italian pharmacies with high-quality THC and CBD Active Pharmaceutical Ingredients (API), serving a burgeoning market demand.
- Two primary product lines will focus on CBD solutions, catering to both human and animal health sectors and expanding market reach across multiple demographics.
- Strong market interest is evidenced by over 100 Italian pharmacies already expressing interest in purchasing CBD and THC products directly from the business.
- Recognized for excellence, the company has received an agriculture award, highlighting its innovative cannabis cultivation methods and establishing it as a leader in Italian agriculture.
- Positioned within the alternative medicine industry, the business capitalizes on the growing trend towards natural and plant-based therapeutic options in Europe.
Products & Services Overview
The business's top-selling products will be two lines of CBD products: one tailored for humans and the other for animals.
Assets Overview
Intangible assets: 2 patterns of cannabis registered till 2045 at CPVO.
Facilities Overview
The GMP EU facility, located in a 660 m² area in Northern Italy, needs to be fully equipped to begin operations and authorized by AIFA, for which the company is consulting for the specific requirements of GMP EU compliance.
Capitalization Overview
Zero debt.
Has 2 shareholders with 98% and 2% stakes.
Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
1 Investor contacted this Business this month. Register below to connect now!
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses
    Frequently
    Asked
    Questions
    • Why can’t I see the business’ name or contact number? How do I contact the business?
    • What level of due diligence does SMERGERS conduct on the businesses/member?
    • How active are the business profiles listed on SMERGERS?
    • How does SMERGERS rate business profiles?
    • Do I need to pay to connect with a business?
    • Show more